Page last updated: 2024-08-24

capecitabine and Thyroid Neoplasms

capecitabine has been researched along with Thyroid Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (66.67)29.6817
2010's0 (0.00)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Liu, J; Pan, X; Tang, W; Wang, J; Wang, S; Ye, T; Zheng, X1
Mittal, BR; Panda, N; Satapathy, S; Sood, A; Verma, R1
Bauer, A; Francis, GL; Helms, A; Patel, A; Pluim, T; Tuttle, RM1
Gilliam, LK; Kohn, AD; Lalani, T; Livingston, RB; Patel, A; Pickett, CA; Swanson, PE; Vasko, V1
Brun, V; Gravis, G; Labidi, SI; Tarpin, C; Viens, P1
Michelin, OC; Paiva, CE1

Other Studies

6 other study(ies) available for capecitabine and Thyroid Neoplasms

ArticleYear
Efficacy and safety of anlotinib-based chemotherapy for locally advanced or metastatic anaplastic thyroid carcinoma.
    Endocrine, 2023, Volume: 81, Issue:3

    Topics: Capecitabine; Humans; Paclitaxel; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms

2023
Efficacy and safety of concomitant 177Lu-DOTATATE and low-dose capecitabine in advanced medullary thyroid carcinoma: a single-centre experience.
    Nuclear medicine communications, 2020, Volume: 41, Issue:7

    Topics: Aged; Capecitabine; Carcinoma, Neuroendocrine; Dose-Response Relationship, Drug; Endpoint Determination; Humans; Male; Neoplasm Metastasis; Octreotide; Organometallic Compounds; Retrospective Studies; Safety; Thyroid Neoplasms

2020
Enzyme expression profiles suggest the novel tumor-activated fluoropyrimidine carbamate capecitabine (Xeloda) might be effective against papillary thyroid cancers of children and young adults.
    Cancer chemotherapy and pharmacology, 2004, Volume: 53, Issue:5

    Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Papillary; Child; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Humans; Immunohistochemistry; Male; Thymidine Phosphorylase; Thymidylate Synthase; Thyroid Neoplasms

2004
Capecitabine therapy for refractory metastatic thyroid carcinoma: a case series.
    Thyroid : official journal of the American Thyroid Association, 2006, Volume: 16, Issue:8

    Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoembryonic Antigen; Deoxycytidine; Dihydrouracil Dehydrogenase (NADP); Female; Fluorouracil; Humans; Iodine Radioisotopes; Male; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Thymidine Phosphorylase; Thyroglobulin; Thyroid Neoplasms

2006
Medullary thyroid cancer treated by capecitabine.
    Anti-cancer drugs, 2007, Volume: 18, Issue:7

    Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Capecitabine; Carcinoma, Medullary; Cisplatin; Deoxycytidine; Doxorubicin; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Metastasis; Palliative Care; Thyroid Neoplasms; Treatment Outcome

2007
Use of capecitabine in refractory metastatic medullary thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2008, Volume: 18, Issue:5

    Topics: Adult; Antimetabolites, Antineoplastic; Capecitabine; Carcinoma, Medullary; Deoxycytidine; Fluorouracil; Humans; Male; Neoplasm Metastasis; Thyroid Neoplasms

2008